Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:1917-1920
Published online before print March 19, 2009, doi: 10.1161/STROKEAHA.108.536698
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/5/1917    most recent
STROKEAHA.108.536698v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramírez-Moreno, J. M.
Right arrow Articles by Serrano, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramírez-Moreno, J. M.
Right arrow Articles by Serrano, A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Intracerebral Hemorrhage
Right arrow Lipid and lipoprotein metabolism

(Stroke. 2009;40:1917.)
© 2009 American Heart Association, Inc.


Research Letters

Serum Cholesterol LDL and 90-Day Mortality in Patients With Intracerebral Hemorrhage

José María Ramírez-Moreno, MD; Ignacio Casado-Naranjo, MD; Juan Carlos Portilla, MD; María Luisa Calle, MD; David Tena, MD; Alfonso Falcón, MD Ana Serrano, MD

From the Section of Neurology (J.M.R.-M.), Infanta Cristina Universitary Hospital, Badajoz, Spain; and the Stroke Unit, Section of Neurology (I.C.-N., J.C.P., M.C., D.T., A.F., A.S.), San Pedro de Alcántara Hospital, Cáceres, Spain.

Correspondence to José María Ramírez-Moreno, MD, Department of Neurology, Infanta Cristina Universitary Hospital, Avenida de Elvas s/n. 06080 Badajoz, Spain. E-mail jramirezm{at}meditex.es

Background and Purpose— Prognostic significance of low-density lipoprotein cholesterol (LDL-C) in intracranial hemorrhage (ICH) is unclear. The objective of this study was to determine the association between LDL-C and mortality in ICH.

Methods— Consecutive patients (n=88) presenting with ICH were included in the study. Lipid profile was obtained during the first hours after admission. We analyzed the impact of LDL-C on 90-day mortality using the Hazard Rate (HR) crude, analysis crude for trend by Mantel–Haenszel Test, Multiple Cox Proportional Hazards model, and analysis of survival curves. Association between LDL-C and severity markers of ICH were explored using Spearman correlation coefficient.

Results— Low LDL-C levels were independently associated with death after intracranial hemorrhage (HR=3.07 (95% CI:1.04 to 9.02; P=0.042) in multivariable analysis after controlling for confounding factors. Analysis for trend showed a significant association (Xt=–2.144; P=0.032) by Mantel-Haenszel Test. Spearman analysis showed no correlation between LDL-C and variables that are markers of ICH severity: NIH score (r=–0.091; P=0.400), GCS score (r=0.136; P=0.207), ICH volume (r=0.140; P=0.192), and length of stay (r=–0.111; P=0.308).

Conclusions— Low levels of LDL-C are independently associated with an increased risk of death in patients with brain hemorrhage. We have not found evidences that the levels of LDL-C can act as a biological marker of severity.


Key Words: cardiovascular disease • intracerebral haemorrhage • prognosis • cholesterol • low-density lipoprotein cholesterol